| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 202906 |
dBET6 PROTAC蛋白降解靶向联合体 |
295 |
wff |
2023-11-16 |
| 202907 |
15:0 PC 3355-27-9 1,2-二十五酰基卵磷脂 |
390 |
LYQ |
2023-11-16 |
| 202908 |
ZXH-3-26 PROteolysis-TArgeting Chimeras 技术 |
252 |
wff |
2023-11-16 |
| 202909 |
ARV-825 PROTAC蛋白降解靶向联合体 |
365 |
wff |
2023-11-16 |
| 202910 |
PROTAC ERRα Degrader-3 泛素-蛋白酶体系统靶蛋白 |
299 |
wff |
2023-11-16 |
| 202911 |
13:0 PC 71242-28-9 1,2-二十三烷酰基-sn-甘油-3-磷酸胆碱 |
253 |
LYQ |
2023-11-16 |
| 202912 |
PROTAC AR-V7 degrader-1 蛋白水解靶向嵌合分子 |
245 |
wff |
2023-11-16 |
| 202913 |
cas:6974-32-9 1-乙酰氧基-2,3,5-三苯甲酰氧基-1-β-D-呋喃核糖 |
330 |
zyl |
2023-11-16 |
| 202914 |
PROTAC STING Degrader-1 蛋白水解靶向嵌合体 |
459 |
wff |
2023-11-16 |
| 202915 |
cas:84297-22-3 1-萘基-Β-D-甘露糖苷 1-naphthyl-b-d-mannose的密度 |
282 |
zyl |
2023-11-16 |
| 202916 |
CP-10 PROteolysis-TArgeting Chimeras 技术 |
259 |
wff |
2023-11-16 |
| 202917 |
PROTAC RIPK degrader-6 小分子抑制剂 |
292 |
wff |
2023-11-16 |
| 202918 |
16:0 2-PC 1,3-二棕榈酰rac-甘油-2-磷酸胆碱 1,3-dipalmitoyl-rac-glycero-2-phosphocholine |
260 |
LYQ |
2023-11-16 |
| 202919 |
11:0 PC 27869-47-2 L-α-磷脂酰胆碱 |
270 |
LYQ |
2023-11-16 |
| 202920 |
PCL-PEG-Pemetrexed,聚己内酯-聚乙二醇-培美曲塞 |
261 |
lcy |
2023-11-16 |
| 202921 |
PCL-PEG-Raltitrexed,聚己内酯-聚乙二醇-雷替曲塞 |
254 |
lcy |
2023-11-16 |
| 202922 |
PCL-PEG-Metronidazole,聚己内酯-聚乙二醇-甲硝唑 |
252 |
lcy |
2023-11-16 |
| 202923 |
10:0 PC 3436-44-0 二癸酰基卵磷脂 |
258 |
LYQ |
2023-11-16 |
| 202924 |
PCL-PEG-Ferrocene,聚己内酯-聚乙二醇-二茂铁 |
234 |
lcy |
2023-11-16 |
| 202925 |
09:0 PC 27869-45-0 1,2-二壬酰-Sn-甘油-3-磷酰胆碱 |
356 |
LYQ |
2023-11-16 |
| 202926 |
PCL-PEG-Dopamine,聚己内酯-聚乙二醇-多巴胺 |
248 |
lcy |
2023-11-16 |
| 202927 |
PCL-PEG-R8,聚己内酯-聚乙二醇-R8,纯度≥95%,溶于大部分有机溶剂 |
308 |
lcy |
2023-11-16 |
| 202928 |
Azide-PEG4-Br，CAS1951439-37-4，溴代四聚乙二醇叠氮，分子量326.19 |
243 |
axc |
2023-11-16 |
| 202929 |
PCL-PEG-MMPs,聚己内酯-聚乙二醇-MMPs,溶于大部分有机溶剂 |
248 |
lcy |
2023-11-16 |
| 202930 |
Azide-PEG3-Br，CAS1446282-43-4，溴代三聚乙二醇叠氮，分子量282.14 |
273 |
axc |
2023-11-16 |
| 202931 |
Azide-PEG7-OTs，CAS1418561-41-7，叠氮七聚乙二醇对甲苯磺酸酯，分子量505.58 |
290 |
axc |
2023-11-16 |
| 202932 |
PCL-PEG-WSW,聚己内酯-聚乙二醇-WSW |
242 |
lcy |
2023-11-16 |
| 202933 |
Azide-PEG5-OTs，CAS236754-49-7，叠氮五聚乙二醇对甲苯磺酸酯，分子量: 417.48 |
269 |
axc |
2023-11-16 |
| 202934 |
azido-PEG10-OH，cas:73342-16-2，叠氮-PEG10-羟基，分子量：571.65876 |
277 |
axc |
2023-11-16 |
| 202935 |
PCL-PEG-YIGSR,聚己内酯-聚乙二醇-YIGSR |
240 |
lcy |
2023-11-16 |
| 202936 |
PCL-PEG-CCK8,聚己内酯-聚乙二醇-生物活性CCK8肽 |
274 |
lcy |
2023-11-16 |
| 202937 |
azido-PEG5-OH，cas:86770-68-5，叠氮-PEG5-羟基，分子量：263.29 |
232 |
axc |
2023-11-16 |
| 202938 |
PCL-PEG-Octreotide,聚己内酯-聚乙二醇-奥曲肽,纯度≥95% |
245 |
lcy |
2023-11-16 |
| 202939 |
PCL-PEG-CDDP,聚己内酯-聚乙二醇-顺铂,纯度≥95% |
239 |
lcy |
2023-11-16 |
| 202940 |
PCL-PEG-DOX 聚己内酯-聚乙二醇-阿霉素 |
261 |
lcy |
2023-11-16 |
| 202941 |
PCL-PEG-Dextran,聚己内酯-聚乙二醇-葡聚糖 |
249 |
lcy |
2023-11-16 |
| 202942 |
Azido-PEG2-PFP ester，CAS: 1393330-37-4，叠氮-PEG2-PFP酯，分子量：369.3 |
252 |
axc |
2023-11-16 |
| 202943 |
N3-tetra-EGOPFP 抗体-药物偶联物 |
269 |
wff |
2023-11-16 |
| 202944 |
Azido-PEG8-TFP ester，cas:1818294-49-3，分子量：615.58 |
259 |
axc |
2023-11-16 |
| 202945 |
PY-DS-DMBUT-OPFP 2101206-44-2 |
258 |
wff |
2023-11-16 |
| 202946 |
Phe-Lys(Trt)-PAB 1116085-99-4 |
214 |
wff |
2023-11-16 |
| 202947 |
Fmoc-Val-Cit-PAB 159858-22-7 |
292 |
wff |
2023-11-16 |
| 202948 |
Azido-PEG4-TFP ester，cas:1807505-33-4，分子量：439.36 |
274 |
axc |
2023-11-16 |
| 202949 |
PCL-PEG-ConA,聚己内酯-聚乙二醇-刀豆球蛋白A |
231 |
lcy |
2023-11-16 |
| 202950 |
VAL-CIT-PAB 159857-79-1 用途：科研 状态：固体/粉末/溶液 |
276 |
wff |
2023-11-16 |
齐岳微信公众号
官方微信
库存查询